Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

4.

Olanzapine in long-term treatment for bipolar disorder.

Cipriani A, Rendell JM, Geddes J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004367. doi: 10.1002/14651858.CD004367.pub2. Review.

PMID:
19160237
5.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

6.

Clinical highlights in bipolar depression: focus on atypical antipsychotics.

Calabrese JR, Elhaj O, Gajwani P, Gao K.

J Clin Psychiatry. 2005;66 Suppl 5:26-33. Review.

7.

The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.

Lee HB, Yoon BH, Kwon YJ, Woo YS, Lee JG, Kim MD, Bahk WM.

Clin Drug Investig. 2013 Oct;33(10):743-53. doi: 10.1007/s40261-013-0120-y. Review.

PMID:
23990283
8.

Olanzapine: a review of its use in the management of bipolar I disorder.

McCormack PL, Wiseman LR.

Drugs. 2004;64(23):2709-26. Review.

PMID:
15537371
9.

Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.

Cipriani A, Rendell J, Geddes JR.

J Psychopharmacol. 2010 Dec;24(12):1729-38. doi: 10.1177/0269881109106900. Epub 2009 Oct 14. Review.

PMID:
19828571
10.

Polytherapy in bipolar disorder.

Lin D, Mok H, Yatham LN.

CNS Drugs. 2006;20(1):29-42. Review.

PMID:
16396522
11.

Olanzapine: in adolescents with schizophrenia or bipolar I disorder.

McCormack PL.

CNS Drugs. 2010 May;24(5):443-52. doi: 10.2165/11204430-000000000-00000. Review.

PMID:
20369908
12.

Olanzapine - relapse prevention following mania.

Dando S, Tohen M.

J Psychopharmacol. 2006 Mar;20(2 Suppl):31-8. Review.

PMID:
16551670
13.

A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.

Yatham LN.

J Affect Disord. 2011 Jan;128 Suppl 1:S21-8. doi: 10.1016/S0165-0327(11)70005-2. Review.

PMID:
21220077
14.

Aripiprazole alone or in combination for acute mania.

Brown R, Taylor MJ, Geddes J.

Cochrane Database Syst Rev. 2013 Dec 17;(12):CD005000. doi: 10.1002/14651858.CD005000.pub2. Review.

PMID:
24346956
15.

Use of olanzapine in the treatment of bipolar I disorder.

Lieberman DZ, Goodwin FK.

Expert Rev Neurother. 2004 Sep;4(5):759-67. Review.

PMID:
15853503
16.

Typical and atypical antipsychotics in bipolar depression.

Gao K, Gajwani P, Elhaj O, Calabrese JR.

J Clin Psychiatry. 2005 Nov;66(11):1376-85. Review.

PMID:
16420074
17.

[Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].

Bánki CM.

Psychiatr Hung. 2007;22(4):311-20. Review. Hungarian.

PMID:
18167425
18.

Olanzapine: a review of its use in the treatment of bipolar I disorder.

Bhana N, Perry CM.

CNS Drugs. 2001;15(11):871-904. Review.

PMID:
11700151
19.

Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.

Tarr GP, Glue P, Herbison P.

J Affect Disord. 2011 Nov;134(1-3):14-9. doi: 10.1016/j.jad.2010.11.009. Epub 2010 Dec 9. Review.

PMID:
21145595
20.

Olanzapine/fluoxetine combination for bipolar depression.

Shelton RC.

Expert Rev Neurother. 2006 Jan;6(1):33-9. Review.

PMID:
16466309

Supplemental Content

Support Center